Chi‐An Chen

9k citations
200 papers · 7.6k · 1 hit paper · h-index 39

Impact in

Papers in

Chi‐An Chen

194 papers receiving 7.2k citations

Chi‐An Chen's Hit Papers

Phase I clinical trial of curcumin, a chemopreventive agent, in patients with high-risk or pre-malignant lesions. 2001 · 1.9k citations
1.9k0+8+16Years since publication5001k1.5k

Peers

Chi‐An Chen
Comparison fields: 5 of 157
  • Molecular Medicine 1.2k
  • Reproductive Medicine 732
  • Obstetrics and Gynecology 596
  • Oral Surgery 287
  • Oncology 921
Replace Matthias W. Laschke with:
Matthias W. Laschke Germany
Ming Zhang China
Ling Zhang China
Hue H. Luu United States
Young Tae Kim South Korea
Rex C. Haydon United States
Xiao Chen China
Yan J. Jin China
Ran Chen China
Junfeng Zhang China
Chi‐An Chen relative to Matthias W. Laschke Germany Matthias W. Laschke's profile →
Citations per field
00.5×5×10×17.0×
Matthias W. Laschke · 1×
Citations per year

Countries citing papers authored by Chi‐An Chen

Since Specialization
Citations

This map shows the geographic impact of Chi‐An Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chi‐An Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chi‐An Chen more than expected).

Fields of papers citing papers by Chi‐An Chen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chi‐An Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chi‐An Chen. The network helps show where Chi‐An Chen may publish in the future.

Co-authors

The 25 scholars most cited alongside Chi‐An Chen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Chi‐An Chen Line = papers co-authored together Chi‐An Chen links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 200 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Phase I clinical trial of curcumin, a chemopreventive agent, in patients with high-risk or pre-malignant lesions.
Hit paper breakdown →
20011862
2 2003467
3 1990313
4 2011303
5 2010165
6 2001152
7 2011137
8 2011127
9 200196
10 201392
11 199991
12 199987
13 201087
14 199983
15 201983
16 200576
17 200875
18 201275
19 200574
20 200372

About Chi‐An Chen

Chi‐An Chen is a scholar working on Obstetrics and Gynecology, Reproductive Medicine, Epidemiology, Immunology and Oncology, having authored 200 papers that have together received 7.6k indexed citations. Recurring topics across this work include Ovarian cancer diagnosis and treatment (35 papers), Endometrial and Cervical Cancer Treatments (29 papers), Cervical Cancer and HPV Research (23 papers), Immunotherapy and Immune Responses (18 papers), Uterine Myomas and Treatments (8 papers), Gestational Trophoblastic Disease Studies (6 papers), Cytokine Signaling Pathways and Interactions (6 papers) and Multiple and Secondary Primary Cancers (5 papers). The work is most often cited by research in Molecular Medicine (1.2k citations), Reproductive Medicine (732 citations), Obstetrics and Gynecology (596 citations), Oral Surgery (287 citations) and Oncology (921 citations). Chi‐An Chen has collaborated with scholars based in Taiwan, United States and Japan. Frequent co-authors include Wen‐Fang Cheng, Chang‐Yao Hsieh, Chien‐Nan Lee, Lin‐Hung Wei, Min‐Liang Kuo, Yu‐Li Chen, Ying‐Cheng Chiang, Chia‐Hung Chou, Ming‐Cheng Chang and Han-Wei Lin. Their work appears in journals such as Gynecologic Oncology, Acta Obstetricia Et Gynecologica Scandinavica, PLoS ONE, Cancer and Molecular Therapy.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact